OTFCX | VIGAX | OTFCX / VIGAX | |
Total Expense Ratio | 1.71 | 0.05 | 3,420% |
Annual Report Gross Expense Ratio | 1.71 | 0.05 | 3,420% |
Fund Existence | 32 years | 25 years | - |
Gain YTD | -0.954 | 1.951 | -49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.61B | 294B | 2% |
Annual Yield % from dividends | 0.00 | 0.46 | - |
Returns for 1 year | 1.22 | 12.60 | 10% |
Returns for 3 years | 60.89 | 91.62 | 66% |
Returns for 5 years | 8.21 | 115.23 | 7% |
Returns for 10 years | -19.12 | 286.61 | -7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECHSX | 12.96 | -0.14 | -1.07% |
Eaton Vance Worldwide Health Sci C | |||
CGVFX | 25.68 | -0.33 | -1.27% |
American Funds Global Insight 529-F-1 | |||
IAVGX | 19.77 | -0.26 | -1.30% |
Voya Growth and Income Port A | |||
HSLSX | 38.82 | -0.64 | -1.62% |
Hartford Small Cap Growth R4 | |||
SEKAX | 19.75 | -0.39 | -1.94% |
DWS Emerging Markets Equity A |